Skip to main content

Table 3 The metabolic response of supradiaphragmatic and retroperitoneal lymphnodes to neoadjuvant chemotherapy

From: Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study

 

Response to first line treatment

Supradiaphragmatic lymphnodes

Retroperitoneal lymphnodes

p value

Complete response after NACT

responders

65% (39/60)

68% (23/34)

0.82

non-responders

30% (11/37)

40% (8/20)

0.55

Mean decrease in SUVmax in sdLNs with partial metabolic response

responders

42%

67%

0.13

non-responders

20%

27%

0.90